Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jan 19:3:9.
doi: 10.3389/fmicb.2012.00009. eCollection 2012.

Extraintestinal Pathogenic Escherichia coli: A Combination of Virulence with Antibiotic Resistance

Johann D D Pitout  1
Affiliations

Extraintestinal Pathogenic Escherichia coli: A Combination of Virulence with Antibiotic Resistance

Johann D D Pitout. Front Microbiol. .

Abstract

Escherichia coli represents an incredible versatile and diverse enterobacterial species and can be subdivided into the following; (i) intestinal non-pathogenic, commensal isolates. (ii) Intestinal pathogenic isolates and (iii) extraintestinal pathogenic E. coli or ExPEC isolates. The presence to several putative virulence genes has been positively linked with the pathogenicity of ExPEC. E. coli remains one of the most frequent causes of nosocomial and community-acquired bacterial infections including urinary tract infections, enteric infections, and systemic infections in humans. ExPEC has emerged in 2000s as an important player in the resistance to antibiotics including the cephalosporins and fluoroquinolones. Most importantly among ExPEC is the increasing recognition of isolates producing "newer β-lactamases" that consists of plasmid-mediated AmpC β-lactamases (e.g., CMY), extended-spectrum β-lactamases (e.g., CTX-M), and carbapenemases (e.g., NDM). This review will highlight aspects of virulence associated with ExPEC, provide a brief overview of plasmid-mediated resistance to β-lactams including the characteristics of the successful international sequence types such as ST38, ST131, ST405, and ST648 among ExPEC.

Keywords: Escherichia coli; antimicrobial resistance; virulence.

PubMed Disclaimer

References

    1. Alvarez M., Tran J. H., Chow N., Jacoby G. A. (2004). Epidemiology of conjugative plasmid-mediated AmpC beta-lactamases in the United States. Antimicrob. Agents Chemother. 48, 533–537 10.1128/AAC.48.2.533-537.2004 - DOI - PMC - PubMed
    1. Canton R., Coque T. M. (2006). The CTX-M beta-lactamase pandemic. Curr. Opin. Microbiol. 9, 466–475 10.1016/j.mib.2006.08.011 - DOI - PubMed
    1. Castanheira M., Deshpande L. M., Mathai D., Bell J. M., Jones R. N., Mendes R. E. (2011a). Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006–2007. Antimicrob. Agents Chemother. 55, 1274–1278 10.1128/AAC.01497-10 - DOI - PMC - PubMed
    1. Castanheira M., Mendes R. E., Woosley L. N., Jones R. N. (2011b). Trends in carbapenemase-producing Escherichia coli and Klebsiella spp. from Europe and the Americas: report from the SENTRY Antimicrobial Surveillance Programme (2007-09). J. Antimicrob. Chemother. 66, 1409–1411 10.1093/jac/dkq393 - DOI - PubMed
    1. Coque T. M., Novais A., Carattoli A., Poirel L., Pitout J., Peixe L., Baquero F., Cantón R., Nordmann P. (2008). Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. Emerg. Infect. Dis. 14, 195–200 10.3201/eid1402.070350 - DOI - PMC - PubMed

LinkOut - more resources